Home
/
NORTHWEST BIOTHERAPEUTICS INC
/
Financials
/
Quarterly
NORTHWEST BIOTHERAPEUTICS INC — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that NORTHWEST BIOTHERAPEUTICS INC filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2024
Mar 31, 2024
$284.0K
May 10, 2024
Q3
2023
Sep 30, 2023
$406.0K
Nov 9, 2023
Q2
2023
Jun 30, 2023
$201.0K
Aug 9, 2023
Q1
2024
Mar 31, 2023
$880.0K
May 10, 2024
Q3
2023
Sep 30, 2022
$206.0K
Nov 9, 2023
Q2
2023
Jun 30, 2022
$477.0K
Aug 9, 2023
Q1
2023
Mar 31, 2022
$403.0K
May 10, 2023
Q3
2022
Sep 30, 2021
$350.0K
Nov 9, 2022
Q2
2022
Jun 30, 2021
$416.0K
Aug 9, 2022
Q1
2022
Mar 31, 2021
$239.0K
May 10, 2022
Q3
2020
Sep 30, 2020
$216.0K
Jan 15, 2021
Q2
2021
Jun 30, 2020
$2.0K
Aug 16, 2021
Q1
2021
Mar 31, 2020
$570.0K
May 17, 2021
Q3
2020
Sep 30, 2019
$593.0K
Jan 15, 2021
Q2
2020
Jun 30, 2019
$581.0K
Aug 10, 2020
Q1
2020
Mar 31, 2019
$339.0K
Jun 24, 2020
Q3
2019
Sep 30, 2018
$453.0K
Nov 12, 2019
Q2
2019
Jun 30, 2018
$278.0K
Aug 9, 2019
Q1
2019
Mar 31, 2018
$132.0K
May 10, 2019
Q3
2018
Sep 30, 2017
$148.0K
Nov 16, 2018
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$200.0K
Nov 14, 2025
Q2
2025
Jun 30, 2025
$131.0K
Aug 14, 2025
Q1
2025
Mar 31, 2025
$375.0K
May 15, 2025
Q3
2025
Sep 30, 2024
$357.0K
Nov 14, 2025
Q2
2025
Jun 30, 2024
$510.0K
Aug 14, 2025
Q1
2025
Mar 31, 2024
$284.0K
May 15, 2025
Q3
2024
Sep 30, 2023
$406.0K
Nov 12, 2024
Q2
2024
Jun 30, 2023
$201.0K
Aug 9, 2024
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2018
Mar 31, 2018
$132.0K
May 16, 2018
Q3
2017
Sep 30, 2017
$148.0K
Nov 20, 2017
Q2
2017
Jun 30, 2017
$88.0K
Aug 21, 2017
Q1
2018
Mar 31, 2017
$68.0K
May 16, 2018
Q3
2017
Sep 30, 2016
$159.0K
Nov 20, 2017
Q2
2017
Jun 30, 2016
$157.0K
Aug 21, 2017
Q1
2017
Mar 31, 2016
$236.0K
May 15, 2017
Q3
2016
Sep 30, 2015
$291.0K
Nov 10, 2016
Q2
2016
Jun 30, 2015
$391.0K
Aug 9, 2016
Q1
2016
Mar 31, 2015
$194.0K
May 11, 2016
Q3
2015
Sep 30, 2014
$582.0K
Nov 9, 2015
Q2
2015
Jun 30, 2014
$0
Aug 10, 2015
Q1
2015
Mar 31, 2014
$0
May 11, 2015
Q3
2014
Sep 30, 2013
$400.0K
Nov 19, 2014
Q2
2014
Jun 30, 2013
$272.0K
Aug 15, 2014
Q1
2014
Mar 31, 2013
$137.0K
May 15, 2014
Q3
2013
Sep 30, 2012
$120.0K
Nov 15, 2013
Q2
2013
Jun 30, 2012
$330.0K
Aug 14, 2013
Q1
2013
Mar 31, 2012
$0
May 15, 2013
Q3
2012
Sep 30, 2011
$10.0K
Nov 14, 2012
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($26.83M)
Nov 14, 2025
Q2
2025
Jun 30, 2025
($15.38M)
Aug 14, 2025
Q1
2025
Mar 31, 2025
($19.34M)
May 15, 2025
Q3
2025
Sep 30, 2024
($19.37M)
Nov 14, 2025
Q2
2025
Jun 30, 2024
($17.87M)
Aug 14, 2025
Q1
2025
Mar 31, 2024
($18.31M)
May 15, 2025
Q3
2024
Sep 30, 2023
($23.52M)
Nov 12, 2024
Q2
2024
Jun 30, 2023
($14.45M)
Aug 9, 2024
Q1
2024
Mar 31, 2023
($10.65M)
May 10, 2024
Q3
2023
Sep 30, 2022
($32.85M)
Nov 9, 2023
Q2
2023
Jun 30, 2022
($29.67M)
Aug 9, 2023
Q1
2023
Mar 31, 2022
($14.21M)
May 10, 2023
Q3
2022
Sep 30, 2021
$45.52M
Nov 9, 2022
Q2
2022
Jun 30, 2021
$4.41M
Aug 9, 2022
Q1
2022
Mar 31, 2021
($4.12M)
May 10, 2022
Q3
2021
Sep 30, 2020
($194.10M)
Nov 15, 2021
Q2
2021
Jun 30, 2020
($58.05M)
Aug 16, 2021
Q1
2021
Mar 31, 2020
$2.63M
May 17, 2021
Q3
2020
Sep 30, 2019
($6.37M)
Jan 15, 2021
Q2
2020
Jun 30, 2019
$219.0K
Aug 10, 2020
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($14.32M)
Nov 14, 2025
Q2
2025
Jun 30, 2025
($14.78M)
Aug 14, 2025
Q1
2025
Mar 31, 2025
($17.31M)
May 15, 2025
Q3
2025
Sep 30, 2024
($14.80M)
Nov 14, 2025
Q2
2025
Jun 30, 2024
($17.46M)
Aug 14, 2025
Q1
2025
Mar 31, 2024
($15.74M)
May 15, 2025
Q3
2024
Sep 30, 2023
($13.83M)
Nov 12, 2024
Q2
2024
Jun 30, 2023
($13.58M)
Aug 9, 2024
Q1
2024
Mar 31, 2023
($12.96M)
May 10, 2024
Q3
2023
Sep 30, 2022
($15.62M)
Nov 9, 2023
Q2
2023
Jun 30, 2022
($21.10M)
Aug 9, 2023
Q1
2023
Mar 31, 2022
($12.29M)
May 10, 2023
Q3
2022
Sep 30, 2021
($10.05M)
Nov 9, 2022
Q2
2022
Jun 30, 2021
($12.41M)
Aug 9, 2022
Q1
2022
Mar 31, 2021
($19.57M)
May 10, 2022
Q3
2021
Sep 30, 2020
($47.88M)
Nov 15, 2021
Q2
2021
Jun 30, 2020
($7.54M)
Aug 16, 2021
Q1
2021
Mar 31, 2020
($7.83M)
May 17, 2021
Q3
2020
Sep 30, 2019
($6.59M)
Jan 15, 2021
Q2
2020
Jun 30, 2019
($6.64M)
Aug 10, 2020